德适-B(02526)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02526 德适-B

休市中 05-22 16:08:20

350.000

+42.400

+13.78%

最高350.000	最低308.000	成交量19.48万
今开308.000	昨收307.600	日振幅13.65%
总市值311.08亿	流通市值311.08亿	总股本8,888万
成交额6,351万	换手率0.22%	流通股本8,888万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02526","market":"HK","secType":"STK","nameCN":"德适-B","latestPrice":350,"timestamp":1779437300983,"preClose":307.6,"halted":0,"volume":194844,"delay":0,"changeRate":0.13784135240572162,"floatShares":88879200,"shares":88879200,"eps":-0.9669981205268644,"marketStatus":"休市中","change":42.4,"latestTime":"05-22 16:08:20","open":308,"high":350,"low":308,"amount":63510709,"amplitude":0.136541,"askPrice":350,"askSize":2350,"bidPrice":349.4,"bidSize":50,"shortable":0,"etf":0,"ttmEps":-0.9635128777728152,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779759000000},"marketStatusCode":7,"adr":0,"listingDate":1774800000000,"exchange":"SEHK","adjPreClose":307.6,"openAndCloseTimeList":[[1779413400000,1779422400000],[1779426000000,1779436800000]],"volumeRatio":1.5656408201094867,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02526","defaultTab":"news","newsList":[{"id":"2637311915","title":"全球首创类医学影像AI首获三类证：德适（02526）AI AutoVision®通过最高等级监管验证，技术护城河再加固","url":"https://stock-news.laohu8.com/highlight/detail?id=2637311915","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637311915?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:11","pubTimestamp":1779451903,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，5月22日，德适发布公告，公司自主研发的AI AutoVision染色体核型辅助诊断软件正式获得国家药监局第三类医疗器械注册证。这是出生缺陷防控、辅助生殖等领域获批速度最快的医学影像AI全球首创类产品，通过中国最高等级医疗器械注册验证。AI AutoVision的获批，直接打开了规模化入院通道，也为后续纳入医保支付体系奠定基础。AI AutoVision获批三类证后，规模化入院通道打开，核心产品催生的收入增长有望进一步加速。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","BK1100","02251","AIPO","BK1189","CHAT","ARTY","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637394428","title":"德适-B(02526)：AI AutoVision®获中国国家药品监督管理局第三类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2637394428","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637394428?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:32","pubTimestamp":1779438757,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德适-B 发布公告，于2026年5月20日，本公司核心产品AI AutoVision已获中国国家药品监督管理局颁发第三类医疗器械注册证。AI AutoVision是基于本集团iMedImage医学影像大模型打造的智能染色体核型分析产品，可辅助完成染色体分割、计数及排列，并提供异常识别提示辅助医师进行临床诊断。该注册证的取得是AI AutoVision的重要监管里程碑，为该核心产品在批准适应症范围内的商业化奠定基础。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK1100","02526","AGIX","CHAT","BK1583","AIPO","BK1574","ARTY","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636304327","title":"“2026智通财经夏季路演大会”活动报名中 ！","url":"https://stock-news.laohu8.com/highlight/detail?id=2636304327","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636304327?lang=zh_cn&edition=full","pubTime":"2026-05-18 10:06","pubTimestamp":1779069961,"startTime":"0","endTime":"0","summary":"5月28日，深圳前海。40+港股上市公司集中路演，与机构及高净值投资者面对面交流。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260518/20260518102433_43763.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260518/20260518102433_43763.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["00305","01300","01907","02706","02411","02889","08299","06651","HK0001040143.USD","00400","VXUS","02726","02675","00826","01396","BK1155","LU0287142896.SGD","02670","01378","BK1100","02228","00650","03858","01021","00363","02729","06090","01384","02650","06938","02526","06682","02575","LU0307460666.USD","03881","06051","09696","01333","02623","02685","06636","02655","LU0314109678.HKD","02142","02652","02659","03317","BK1171","00290","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147563562","title":"异动解读 | 德适-B盘中大涨9.34%，2025年技术许可业务暴增331.7%引爆AI医疗商业闭环","url":"https://stock-news.laohu8.com/highlight/detail?id=1147563562","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147563562?lang=zh_cn&edition=full","pubTime":"2026-05-13 15:30","pubTimestamp":1778657445,"startTime":"0","endTime":"0","summary":"德适-B今日盘中大涨9.34%，引起了市场的广泛关注。消息面上，公司近日披露了2025年业绩报告，显示全年总收入达1.64亿元，同比激增133.7%；毛利1.18亿元，同比大增157%。尤为亮眼的是，技术许可业务收入从上年同期的1954万元飙升至8434万元，同比暴增331.7%，首次占据总营收的半壁江山，跃升为第一大收入来源。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635205747","title":"港股异动 | 德适-B(02526)尾盘涨超9% 全年技术许可暴增331.7% 医疗AI大模型商业闭环可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2635205747","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635205747?lang=zh_cn&edition=full","pubTime":"2026-05-13 15:23","pubTimestamp":1778657027,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德适-B尾盘涨超9%，截至发稿，涨%9.01，报326.8港元，成交额4048.94万港元。消息面上，德适近日披露2025年业绩。全年总收入1.64亿元，同比激增133.7%；毛利1.18亿元、同比大增157%。智通财经APP在《德适-B：技术许可暴增331.7%引爆“造血”元年，以基座模型构筑全球AI医疗基础设施》中指出，德适2025年的年报，无疑是其迄今最有力的一次自我证明。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","02526","150261","VXUS","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117488107","title":"德适-B2026年4月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1117488107","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117488107?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:36","pubTimestamp":1778142999,"startTime":"0","endTime":"0","summary":"杭州德適生物科技股份有限公司（股票代码：02526，股票名称：德适-B）于2026年5月7日发布2026年4月股份变动月报表，报告期为2026年4月1日至4月30日。公告显示，公司注册股本为人民币88,879,200元，至本期末无增减变化；普通股（H股）总数维持在88,879,200股，库藏股份数量为0，股本结构保持不变。\n报告期内，公司无新增发行、购回或注销股份，也无期权及股权激励计划相关变动。公司确认其在本期间持续满足香港联交所《上市规则》及相关法律法规要求。截至2026年4月30日，公司股本及已发行股份总数保持稳定。\n据悉，本次公告由公司执行董事宋宁签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633897050","title":"德适首份年报：全年收入约1.64亿元，同比增约133.7%，毛利率达71.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633897050","media":"广州日报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633897050?lang=zh_cn&edition=full","pubTime":"2026-05-06 11:56","pubTimestamp":1778039819,"startTime":"0","endTime":"0","summary":"“全球医学影像大模型第一股”——杭州德适生物科技股份有限公司（股票代码：2526.HK，以下简称“德适”）日前发布了上市后首份年度业绩报告：公司全年实现收入约1.64亿元，同比实现约133.7%的强劲增长；毛利约1.18亿元，毛利率显著提升至约71.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605063728452275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145540772","title":"异动解读 | 德适-B盘中大涨15.69%，创上市新高，广交会亮相及技术许可收入暴增提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1145540772","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145540772?lang=zh_cn&edition=full","pubTime":"2026-05-04 10:37","pubTimestamp":1777862241,"startTime":"0","endTime":"0","summary":"德适-B(02526)今日盘中大幅上涨15.69%，股价创下上市以来的历史新高，引起了市场的广泛关注。消息面上，公司近期携自主研发的iMedImage®医学影像基座大模型亮相第139届广交会智慧医疗专区，展台吸引了来自中东、东南亚及欧洲等地采购商的浓厚兴趣，市场对其技术实力和国际化前景给予了积极反馈。此外，根据公司2025年年报，其技术许可收入同比暴增332%，成功验证了其大模型商业闭环的可行性。同时，iMedImage®基座模型获得了腾讯等头部机构的战略背书，进一步巩固了其作为全球AI医疗基础设施服务商的行业地位与战略价值，多重利好共同推动了本次股价的强劲表现。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632982546","title":"港股异动 | 德适-B(02526)涨超15%创上市新高 德适携自研iMedImage®医学影像基座大模型亮相广交会","url":"https://stock-news.laohu8.com/highlight/detail?id=2632982546","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632982546?lang=zh_cn&edition=full","pubTime":"2026-05-04 10:27","pubTimestamp":1777861643,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德适-B早盘涨超15%，高见335港元创上市新高，较招股价99港元已涨近240%。德适携自主研发的iMedImage医学影像基座大模型亮相，展台前人流如织，来自中东、东南亚、欧洲等地的采购商对其技术和产品表现出浓厚兴趣。技术许可收入暴增332%，验证了大模型商业闭环的可行性；30.6%的市占率，守住了政策性刚需赛道的绝对领先地位；而iMedImage基座模型获得腾讯等头部机构的背书，则深刻印证了其作为全球AI医疗基础设施服务商的战略价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437759.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1189","02251","IPOS","VXUS","BK4588","BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146307854","title":"德适-B2025年AI影像业务高速扩张，收入同比增133.7%，研发投入大幅攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=1146307854","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146307854?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:36","pubTimestamp":1777473399,"startTime":"0","endTime":"0","summary":"2025年，杭州德适生物科技股份有限公司围绕其核心的数字化与智能化发展战略，在医学影像智能化等智慧医疗领域推进约5,000个项目与3,200余项研发任务，巩固了在AI影像诊断及多元化智慧医疗产品方面的竞争力。公司持续扩展技术许可收入来源，并通过iMedImage、AI AutoVision等医学影像及数字化解决方案，深化与医疗机构的科研与治疗合作，覆盖超声、X光、CT、MRI等多类应用场景及拓展领域。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德适-B2025年AI影像业务高速扩张，收入同比增133.7%，研发投入大幅攀升","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631988395","title":"德适-B(02526)建议采纳股份激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2631988395","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631988395?lang=zh_cn&edition=full","pubTime":"2026-04-29 16:49","pubTimestamp":1777452590,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德适-B(02526)发布公告，董事会已于2026年4月29日举行的董事会会议上决议建议采纳股份激励计划，以促进其长期可持续发展，吸引及留住对集团长期增长及成功作出贡献的合资格参与者，使激励对象、股东及公司的利益保持一致，并优化公司的激励结构。受限制股份单位及购股权的授予应透过以下方式拨付：受托人将于二级市场购买的H股;公司将予发行的新H股;及公司合法持有的库存股份(如有)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","02526","301122","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629049899","title":"德适：iMedImage医学影像基座模型覆盖超90%临床医学影像场景，可将专病AI模型研发成本降低90%以上","url":"https://stock-news.laohu8.com/highlight/detail?id=2629049899","media":"新浪科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629049899?lang=zh_cn&edition=full","pubTime":"2026-04-22 20:27","pubTimestamp":1776860820,"startTime":"0","endTime":"0","summary":"新浪科技讯 4月22日晚间消息，在2026第十届万物生长大会上，杭州德适生物科技股份有限公司携自研iMedImage医学影像基座模型，亮相“杭州AI十八罗汉”联展区。　　本次参展，德适重点展出两大核心产品：自主研发的iMedImage医学影像基座模型，以及基于该模型打造的AI AutoVision 染色体核型辅助诊断软件。据现场负责人介绍，iMedImage支持染色体、CT、MRI、超声及病理等19种医学影像模态，覆盖超90%的临床医学影像场景。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/2026-04-22/doc-inhvkqfy9348178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CHAT","AIPO","BK1189","02251","ARTY","AGIX","BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163417496","title":"德适-B2026年3月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1163417496","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163417496?lang=zh_cn&edition=full","pubTime":"2026-04-22 16:37","pubTimestamp":1776847045,"startTime":"0","endTime":"0","summary":"杭州德适生物科技股份有限公司（股票代码：02526，以下简称“德适-B”）于2026年4月22日披露2026年3月股份变动月报表。报告期内，公司已发行股本及注册股本均无变化，截至当月底仍为88,879,200股，未出现新增发行、购回、注销或库藏股变动。\n根据公告，德适-B本月无股份期权或激励计划变动，也无购回或注销股份行为。公司确认，截至2026年3月31日，已满足相关上市规则及法律法规的合规要求，股本结构保持稳定。\n上述月报由公司执行董事宋宁签署。公司表示将持续遵守香港联交所《上市规则》以及其他相关法律法规的要求，及时披露最新信息。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162235274","title":"异动解读 | 德适-B盘中大涨5.41%，一季度业绩超预期叠加AI产品获批预期驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=1162235274","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162235274?lang=zh_cn&edition=full","pubTime":"2026-04-22 10:01","pubTimestamp":1776823280,"startTime":"0","endTime":"0","summary":"德适-B(02526)今日盘中股价大幅上涨5.41%，引起了市场关注。消息面上，公司此前披露的一季度业绩表现亮眼，净利润达到5.8亿元，同比增长12.3%，毛利率为38.7%，环比提升了2.1个百分点，盈利能力显著超出市场预期。同时，公司旗下的AI AutoVision已被国家药监局认定为三类创新医疗器械，监管机构对其注册批准无异议，目前仅剩程序及行政事宜待完成。若最终获批，该产品将成为国内首款智能染色体核型辅助诊断软件。基本面的改善叠加重要产品的获批预期，共同推动了股价的上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628184757","title":"港股德适-B再涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628184757","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628184757?lang=zh_cn&edition=full","pubTime":"2026-04-20 10:33","pubTimestamp":1776652386,"startTime":"0","endTime":"0","summary":"4月20日，德适-B(02526.HK)再涨超7%，截至发稿涨6.02%，报299.2港元，成交额2743.16万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604203710345353.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604203710345353.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","BK4585","BK1100","02526","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628185327","title":"港股异动 | 德适-B(02526)再涨超7% AI AutoVision有望成为国内首款智能染色体核型辅助诊断软件","url":"https://stock-news.laohu8.com/highlight/detail?id=2628185327","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628185327?lang=zh_cn&edition=full","pubTime":"2026-04-20 10:26","pubTimestamp":1776651969,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德适-B再涨超7%，截至发稿，涨6.02%，报299.2港元，成交额2743.16万港元。目前，AI AutoVision已被国家药监局认定为三类创新医疗器械，德适生物在招股书中披露，公司于2025年12月与国家药监局医疗器械技术审评中心沟通后确认，监管机构对AI AutoVision 的注册批准无异议，目前仅剩余相关程序及行政事宜待完成。若最终获批上市，将成为国内首款获批上市的智能染色体核型辅助诊断软件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"db345349a8b5964f1c0f70e3a421d2db","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK4585","AGIX","CHAT","VGT","159180","02526","VXUS","AIPO","ARTY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184107829","title":"异动解读 | 一季度业绩超预期，德适-B盘中大涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184107829","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184107829?lang=zh_cn&edition=full","pubTime":"2026-04-20 09:46","pubTimestamp":1776649619,"startTime":"0","endTime":"0","summary":"德适-B今日盘中大涨5.60%，引起了市场的广泛关注。消息面上，公司此前披露的一季度业绩表现亮眼，净利润达5.8亿元，同比增长12.3%，盈利能力显著提升，表现超出市场预期，持续获得资金关注。作为医疗保健设备领域企业，德适-B在基本面改善的支撑下延续强势。此外，港股市场整体情绪积极，也为个股表现提供了良好的外部环境。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104386818","title":"异动解读 | 德适-B盘中大涨6.24%，一季度盈利能力显著提升超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1104386818","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104386818?lang=zh_cn&edition=full","pubTime":"2026-04-16 11:59","pubTimestamp":1776311970,"startTime":"0","endTime":"0","summary":"德适-B今日盘中大涨6.24%，报286.2港元，成交额约1369万港元，引起了市场的广泛关注。消息面上，公司一季度盈利能力显著提升，净利润达5.8亿元，同比增长12.3%，业绩表现超出市场预期，是推动股价走强的核心因素。作为医疗保健设备领域企业，德适-B在基本面改善的支撑下获得了资金的积极关注。此外，港股市场整体新股融资活跃，一季度港股新股融资额达1099亿港元，位居全球第一，市场情绪较为积极，也为个股表现提供了良好的外部环境。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152107025","title":"德适-B3月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1152107025","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152107025?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:31","pubTimestamp":1775723485,"startTime":"0","endTime":"0","summary":"德适-B于2026年4月9日发布2026年3月股份变动月报，报告期截至2026年3月31日。公告显示，报告期内公司已发行股份及注册股本未发生增减变动。截至2026年3月31日，各类股份的已发行总数与上月结存保持一致，均为88,879,200股，未出现新增发行、购回、注销或库藏股变动。另外，公司在本月无股份期权及股权激励计划的授出、行使或失效记录，亦未披露任何与可换股票据、权证或其他订立发行公司股份的安排。本次月报由公司执行董事宋宁签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625477993","title":"港股异动 | 德适-B(02526)涨超7% 核心业务为医学影像AI基座大模型","url":"https://stock-news.laohu8.com/highlight/detail?id=2625477993","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625477993?lang=zh_cn&edition=full","pubTime":"2026-04-08 09:46","pubTimestamp":1775612815,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，“医学影像大模型第一股”德适-B今早涨超7%，截至发稿，涨6.84%，报250港元，成交额1878.41万港元。此外，公司的核心产品AI AutoVision已获国家药品监督管理局认定为三类创新医疗器械，有望成为全国首款获批上市的智能染色体核型辅助诊断软件。2025年前9个月，公司实现营收同比激增469.8%达1.12亿元，毛利率高达75.9%，其中技术许可业务毛利率更是达到96.5%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK4588","AIPO","VXUS","02526","ARTY","02251","BK4585","AGIX","CHAT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.diagens.com","stockEarnings":[{"period":"1week","weight":0.1643},{"period":"1month","weight":0.2094},{"period":"3month","weight":2.5354},{"period":"ytd","weight":2.5354}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0306},{"period":"6month","weight":0.0153},{"period":"1year","weight":0.0876},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州德适生物科技股份有限公司(简称“德适生物”),是全球医学影像AI与医疗影像装备领域的领先企业,业务覆盖全球市场。依托自主研发的通用医学影像基座模型iMedImage,公司成功打造出多元化的智能装备及配套产品矩阵,包括AutoVision染色体核型分析系统、MetaSight自动细胞显微图像扫描系统、KayoFlow自动细胞收获仪与制片染色一体机等,可满足临床多场景需求。公司客户已覆盖全国400多家医疗保健中心与医疗机构,获得市场广泛认可。未来,公司将持续为全球客户提供标准化智能成像设备、模型即服务(MaaS)云平台及本地化自训练解决方案,以技术创新提升医学影像诊断的效率、准确率与可及性,引领全球医学影像行业进入智能化时代。","exchange":"SEHK","name":"德适-B","nameEN":"DIAGENS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德适-B(02526)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德适-B(02526)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德适-B,02526,德适-B股票,德适-B股票老虎,德适-B股票老虎国际,德适-B行情,德适-B股票行情,德适-B股价,德适-B股市,德适-B股票价格,德适-B股票交易,德适-B股票购买,德适-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德适-B(02526)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德适-B(02526)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}